Zdrowie i gospodarka · 06/11/2012

FDA Releases Draft Guidance for Lenalidomide Bioequivalence Studies

The US Food and Drug Administration (FDA) has made available a draft guidance document outlining specific recommendations for designing bioequivalence studies to support abbreviated new drug applications (ANDAs) for lenalidomide capsules, a treatment for certain blood disorders.